REVIEW
|
doi:10.20944/preprints202306.0932.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
gastric cancer; HER2; immunotherapy; PD-1/PD-L1; antibody-drug conjugate; chemotherapy; trastuzumab; novel therapies; clinical trials
Online: 13 June 2023 (11:15:24 CEST)